Scotland · NHS Scotland MSAN
Ramipril 1.25mg capsules
MSAN(2026)15 · Level 2 · issued 27 Apr 2026
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 2. Ramipril 1.25mg and 2.5mg tablets and ramipril oral solution remain available but cannot | Available | — |
| angiotensin-II receptor blockers (ARBs) remain available, some of which can support increased | Available | — |
| 6. Where supplies of ramipril 1.25mg capsules are available, community pharmacists and | Available | — |
| 10. Please note, other low/lower strength formulations of ACE inhibitors and ARBs remain available | Available | — |
| but if not listed above, they cannot support increased demand. | Available — cannot support uplift | — |
| you need to register with the SPS website. Registration for access to the website is available to | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.